|
Match
|
Document |
Document Title |
|
|
6187339 |
Solid pharmaceutical composition comprising an excipient capable of binding water
The invention concerns a solid pharmaceutical composition comprising less than 7% by weight of an oil or oily substance, a low dosage active ingredient, and a water insoluble non-cross-linked...
|
|
|
6177416 |
Oxyiminopregnancarbolactones
3-Oxyiminopregnane-21-carbolactones of formula I, ##STR1## wherein R is as defined by the specification, their production and use as pharmaceutical agents are described.
|
|
|
6156742 |
Emergency contraceptive kit
A kit which is adapted and designed to provide both data on the current reproductive status of a patient, and contraception for those who are not pregnant, but recently engaged in unprotected sex.
|
|
|
6139873 |
Combined pharmaceutical estrogen-androgen-progestin
Disclosed are methods and compositions for oral contraception and for hormone replacement therapy. Certain compositions of the invention contain androgens, preferably methyltestosterone to be taken...
|
|
|
6133251 |
Combination compound for contraception based on natural estrogen
The combination preparation for contraception includes a first stage of 2 to 4 first stage daily dosage portions, a second stage of two groups of second stage daily dosage portions, a third stage...
|
|
|
6117429 |
Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
A method for reducing potential adverse effects of androgenic testosterone precursors by interfering with production or action of testosterone and estrogen metabolites by nutrient combinations is...
|
|
|
6113949 |
Weight control product and method of treating hyperlipidemia and increasing vigor with said product
This invention relates to a weight control composition, preferably in the form of a capsule or tablet, comprising a mixture of guggul extract and at least one phosphate salt selected from calcium...
|
|
|
6096731 |
Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
A method for preventing tissue damage associated with graft-versus-host disease in a patient having undergone hematopoietic cell transplantation, and host-versus-graft disease in a patient having...
|
|
|
6093389 |
Methods and compositions for attracting and controlling termites
The present invention provides a composition for attracting termites containing a steroid derivative of formula I ##STR1## The present invention also provides a method for attracting or controlling...
|
|
|
6087350 |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
The present invention provides a method of killing a cell by first administering to the cell a vitamin D derivative and subsequently administering to the cell a cytotoxic agent. Where the cell is...
|
|
|
6066676 |
Pharmaceutical composition and methods for using it
Disclosed is a method of treating problems or disorders of the human nervous system or a method of imparting an anaesthetic effect, by applying to a patient in need of such treatment a...
|
|
|
6066627 |
Steroids as neurochemical initiators of change in human blood levels of LH
The invention relates to a method of altering the blood levels of LH or FSH in an individual. The method comprises nasally administering a steroid which is a human vomeropherin, such that the...
|
|
|
RE36701 |
Coronary heart disease treated with oestradiol
Use of 17β-oestradiol in the treatment of coronary heart disease.
|
|
|
6054447 |
Progesterone for treating or reducing ischemia
The present invention provides a method of treating or reducing ischemia or incidence of cardiovascular events by administering progesterone. Progesterone, unlike synthetic progestins, has been...
|
|
|
6046183 |
Method of synergistic treatment for benign prostatic hyperplasia
Disclosed is an improved treatment for men with benign prostatic hyperplasia (BPH), involving combination therapy of a 5α-reductase inhibitor, e.g. a 17β-substituted 4-azasteroid, a...
|
|
|
6043234 |
Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen
This invention relates to the use of a product that contains in combination individual dosage units of a competitive progesterone antagonist and individual dosage units of a gestagen for its...
|
|
|
RE36606 |
Synergistic pharmaceutical compositions
A pharmaceutical composition comprises a synergistic combination of about 0.01-0.15% by wt. triamcinolone acetonide and about 0.04-0.3% by wt. halcinonide as active ingredients, in combination with...
|
|
|
6020327 |
Control of hair growth
A method for treating hair loss is disclosed by topically adminstering an aromatase inhibitor to a mammal, including humans, on the area to be treated.
|
|
|
6013642 |
Use of estrone derivatives as steroid sulphatase inhibitors
|
|
|
5994333 |
Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e.g. a pregnane or cholane steroid, or a...
|
|
|
5985877 |
Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
A method of treating prostate cancer by co-administering a tyrosine kinase inhibitor such as an indolocarbazole and a chemical castration agent is disclosed. A composition containing a tyrosine...
|
|
|
5980940 |
Pharmaceutical combination preparation for hormonal contraception
The invention provides a pharmaceutical combination preparation with two hormone components in a packaging unit and intended for time-sequential oral administration, comprising a number of daily...
|
|
|
5962443 |
19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e.g. a 19-nor pregnane steroid, or a...
|
|
|
5952318 |
Treatment of HIV positive patients
A mixture of betasitosterol and betasitosteryl glycoside in a ratio of between 1:1 and 500:1 is administered to an HIV infected individual. This has the effect of stabilizing CD4 cell numbers,...
|
|
|
5929058 |
Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes
Methods for treating non-insulin dependent Diabetes Mellitus (NIDDM), or Type II Diabetes, by administering a combination of treatment agents exhibiting glucocorticoid receptor type I agonist...
|
|
|
RE36247 |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
A method of hormonally treating menopausal (including perimenopausal and post-menopausal) disorders in women, a composition, and a multi-preparation pack therefor. The administrative regimen to...
|
|
|
5898032 |
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to...
|
|
|
5891867 |
Hormonal medicaments and their use for the correction of oestrogenic deficiencies
A method of treating estrogen deficiencies in menopausal women by the oral administration of an estrogen alone followed by an estrogen progestogen combination and then a placebo.
|
|
|
5888543 |
Oral contraceptives
This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily...
|
|
|
5885978 |
External therapeutic composition for dermatitis
The present invention provides an external therapeutic composition for dermatitis comprising an aqueous solution including a therapeutically effective amount of an adrenal cortical steroid, a...
|
|
|
5861387 |
Controlled release systems and low dose androgens
Methods of treatment and prevention of estrogen-related diseases, and of fertility control, include low dose (e.g. less than 50 nanomolar serum concentration) administration of certain anabolic...
|
|
|
5861391 |
Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
The present invention provides a method of treating an individual with primary adrenal insufficiency, comprising the step of administering an effective amount of dehydroepiandrosterone to said...
|
|
|
5859000 |
Method for reducing mast cell mediated allergic reactions
The present invention is directed to a method for reducing mast cell mediated allergic reactions, including mast cell mediated allergy and asthma. Mast cell mediated allergic reactions, including...
|
|
|
5846960 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds
A method of treatment or prevention of breast and endometrial cancer, osteoporosis and endometriosis in susceptible warm-blooded animals comprising administering a low dose of a progestin or other...
|
|
|
5827841 |
Method for enhancement of production of lymphokines and applications thereof
Disclosed is a method for enhancing the production of T cell lymphokines, which comprises exposing T cell lymphocytes which have a potential to make selected T cell lymphokines to an appropriate...
|
|
|
5827843 |
Preparation for substitution therapy, containing at least one progestogen and at least one estrogen
The invention relates to a preparation for substitution therapy and oral contraception comprising at least one progestogen and at least one estrogen in which the estrogen dose varies with a...
|
|
|
5824668 |
Formulation for administration of steroid compounds
Disclosed are compositions including at least one 5β steroid and an amorphous cyclodextrin. Also disclosed are methods for treating a condition such as obesity, diabetes syndrome,...
|
|
|
5817650 |
Treatment of systemic lupus erythematosus with dehydroepiandrosterone
Systemic lupus erythematosus (SLE) is treated with dehydroepiandrosterone or its metabolite, sulfate ester, by itself or in combination with other therapies. Substantial improvement in SLE patients...
|
|
|
5814624 |
Method for obtaining estrogens from pregnant mare urine by solid-phase extraction
A method for obtaining an extract from urine of pregnant mares containing a natural mixture of conjugated estrogens by solid-phase extraction of the mixture of conjugated estrogens from the urine...
|
|
|
5795882 |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
Method of treating prostatic conditions such as prostate cancer and hyperplasia by administering 1α-hydroxyprevitamin D or activated vitamin D or a combination thereof in a sustained release form...
|
|
|
5795881 |
Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
A pharmaceutical agent contains a progesterone synthesis inhibitor (ProI) of the trilostane or epostane type and an antigestagen (AG). It can be used for inducing delivery at term in humans and...
|
|
|
5792757 |
19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human vomeropherin, e.g. a 19-nor pregnane steroid, or a...
|
|
|
5763430 |
Method of treating a viral infection by administering a steroid compound
A method of treating a viral infection includes administering an effective amount of a compound having the following structure: ##STR1## or a pharmaceutically acceptable salt thereof. This compound...
|
|
|
5763431 |
Method for regulating neuropeptide hormone secretion
Methods are described for regulating neuropeptide secretion to alleviate premature labor, hypertension, fluid imbalance, and risk of heart disease using neuroactive steroids targeted for a...
|
|
|
5759577 |
Controlled release of steroids from sugar coatings
A compressed medicinal tablet comprising a tablet core and a sugar coating, said sugar coating containing a dose of a hormonal steroid and a steroid release rate controlling amount of...
|
|
|
5756490 |
Pharmaceutical combination preparation for hormonal contraception
A pharmaceutical combination preparation with two hormone components that are manufactured physically separately in a packaging unit and that are intended for time-sequential oral administration,...
|
|
|
5753713 |
Method for promoting hair growth
Disclosed is a pharmaceutical composition intended for the topical application to human skin, comprising (A) as an effective ingredient, a mixture comprising (1) an antibiotic medication; ...
|
|
|
5753639 |
Low dose androgenic compounds for prevention and treatment of endometriosis
A method of treatment or prevention of breast and endometrial cancer, osteoporosis and endometriosis in susceptible warm-blooded animals comprising administering a low dose of a progestin or other...
|
|
|
5753247 |
Method of treating fungal infections
Disclosed is a pharmaceutical composition intended for the topical application to human skin, comprising (A) as an effective ingredient, a mixture comprising (1) an antibiotic medication; ...
|
|
|
5744463 |
Treatment of side effects of progestins and progesterone analogues used for birth control
The present invention provides methods for treating the deleterious effects of progestins and progesterone analogues used for birth control. The invention also provides pharmaceutical compositions...
|